{
  "symbol": "MO",
  "year": 2022,
  "Period": "Q3",
  "report_type": "Q10",
  "metrics": {
    "mdna_sentiment": 0.0,
    "outlook_sentiment": 0.1636,
    "forward_ratio": 1.0,
    "hedge_ratio": 0.174
  },
  "top_positive": [
    {
      "sent": "34 Table of Contents Consolidated Results of Operations for the Three Months Ended March 31, 2022 The changes in net earnings attributable to Altria and diluted earnings per share (\u201cEPS\u201d) attributable to Altria for the three months ended March 31, 2022, from the three months ended March 31, 2021, were due primarily to the following: (in millions, except per share data) Net Earnings Diluted EPS For the three months ended March 31, 2021 $ 1,424 $ 0.77 2021 NPM Adjustment Items (24) (0.01) 2021 Asset impairment, exit, implementation, acquisition and disposition-related costs 37 0.02 2021 Tobacco and health and certain other litigation items 26 0.01 2021 JUUL changes in fair value 200 0.10 2021 ABI-related special items (100) (0.05) 2021 Cronos-related special items (70) (0.04) 2021 Loss on early extinguishment of debt 496 0.27 2021 Income tax items (6) \u2014 Subtotal 2021 special items 559 0.30 2022 NPM Adjustment Items 45 0.02 2022 Asset impairment, exit, implementation, acquisition and disposition-related costs (5) \u2014 2022 Tobacco and health and certain other litigation items (9) \u2014 2022 JUUL changes in fair value (100) (0.05) 2022 ABI-related special items 47 0.02 2022 Cronos-related special items (61) (0.03) 2022 Income tax items (5) \u2014 Subtotal 2022 special items (88) (0.04) Fewer shares outstanding \u2014 0.02 Change in tax rate (4) \u2014 Operations 68 0.03 For the three months ended March 31, 2022 $ 1,959 $ 1.08 2022 Reported Net Earnings $ 1,959 $ 1.08 2021 Reported Net Earnings $ 1,424 $ 0.77 % Change 37.6 % 40.3 % 2022 Adjusted Net Earnings and Adjusted Diluted EPS $ 2,047 $ 1.12 2021 Adjusted Net Earnings and Adjusted Diluted EPS $ 1,983 $ 1.07 % Change 3.2 % 4.7 % For a discussion of special items and other business drivers affecting the comparability of statements of earnings amounts and reconciliations of adjusted earnings attributable to Altria and adjusted diluted EPS attributable to Altria, see the Consolidated Operating Results section below.",
      "score": 0.9879
    },
    {
      "sent": "34 Table of Contents Consolidated Results of Operations for the Three Months Ended March 31, 2022 The changes in net earnings attributable to Altria and diluted earnings per share (\u201cEPS\u201d) attributable to Altria for the three months ended March 31, 2022, from the three months ended March 31, 2021, were due primarily to the following: (in millions, except per share data) Net Earnings Diluted EPS For the three months ended March 31, 2021 $ 1,424 $ 0.77 2021 NPM Adjustment Items (24) (0.01) 2021 Asset impairment, exit, implementation, acquisition and disposition-related costs 37 0.02 2021 Tobacco and health and certain other litigation items 26 0.01 2021 JUUL changes in fair value 200 0.10 2021 ABI-related special items (100) (0.05) 2021 Cronos-related special items (70) (0.04) 2021 Loss on early extinguishment of debt 496 0.27 2021 Income tax items (6) \u2014 Subtotal 2021 special items 559 0.30 2022 NPM Adjustment Items 45 0.02 2022 Asset impairment, exit, implementation, acquisition and disposition-related costs (5) \u2014 2022 Tobacco and health and certain other litigation items (9) \u2014 2022 JUUL changes in fair value (100) (0.05) 2022 ABI-related special items 47 0.02 2022 Cronos-related special items (61) (0.03) 2022 Income tax items (5) \u2014 Subtotal 2022 special items (88) (0.04) Fewer shares outstanding \u2014 0.02 Change in tax rate (4) \u2014 Operations 68 0.03 For the three months ended March 31, 2022 $ 1,959 $ 1.08 2022 Reported Net Earnings $ 1,959 $ 1.08 2021 Reported Net Earnings $ 1,424 $ 0.77 % Change 37.6 % 40.3 % 2022 Adjusted Net Earnings and Adjusted Diluted EPS $ 2,047 $ 1.12 2021 Adjusted Net Earnings and Adjusted Diluted EPS $ 1,983 $ 1.07 % Change 3.2 % 4.7 % For a discussion of special items and other business drivers affecting the comparability of statements of earnings amounts and reconciliations of adjusted earnings attributable to Altria and adjusted diluted EPS attributable to Altria, see the Consolidated Operating Results section below.",
      "score": 0.9879
    },
    {
      "sent": "34 Table of Contents Consolidated Results of Operations for the Three Months Ended March 31, 2022 The changes in net earnings attributable to Altria and diluted earnings per share (\u201cEPS\u201d) attributable to Altria for the three months ended March 31, 2022, from the three months ended March 31, 2021, were due primarily to the following: (in millions, except per share data) Net Earnings Diluted EPS For the three months ended March 31, 2021 $ 1,424 $ 0.77 2021 NPM Adjustment Items (24) (0.01) 2021 Asset impairment, exit, implementation, acquisition and disposition-related costs 37 0.02 2021 Tobacco and health and certain other litigation items 26 0.01 2021 JUUL changes in fair value 200 0.10 2021 ABI-related special items (100) (0.05) 2021 Cronos-related special items (70) (0.04) 2021 Loss on early extinguishment of debt 496 0.27 2021 Income tax items (6) \u2014 Subtotal 2021 special items 559 0.30 2022 NPM Adjustment Items 45 0.02 2022 Asset impairment, exit, implementation, acquisition and disposition-related costs (5) \u2014 2022 Tobacco and health and certain other litigation items (9) \u2014 2022 JUUL changes in fair value (100) (0.05) 2022 ABI-related special items 47 0.02 2022 Cronos-related special items (61) (0.03) 2022 Income tax items (5) \u2014 Subtotal 2022 special items (88) (0.04) Fewer shares outstanding \u2014 0.02 Change in tax rate (4) \u2014 Operations 68 0.03 For the three months ended March 31, 2022 $ 1,959 $ 1.08 2022 Reported Net Earnings $ 1,959 $ 1.08 2021 Reported Net Earnings $ 1,424 $ 0.77 % Change 37.6 % 40.3 % 2022 Adjusted Net Earnings and Adjusted Diluted EPS $ 2,047 $ 1.12 2021 Adjusted Net Earnings and Adjusted Diluted EPS $ 1,983 $ 1.07 % Change 3.2 % 4.7 % For a discussion of special items and other business drivers affecting the comparability of statements of earnings amounts and reconciliations of adjusted earnings attributable to Altria and adjusted diluted EPS attributable to Altria, see the Consolidated Operating Results section below.",
      "score": 0.9879
    }
  ],
  "top_negative": [
    {
      "sent": "(4) Includes as of April 25, 2022, one inactive smoking and health case alleging personal injury and purporting to be brought on behalf of a class of individual plaintiffs and two inactive class action lawsuits alleging that use of the terms \u201cLights\u201d and \u201cUltra Lights\u201d constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment, breach of warranty or violations of RICO.",
      "score": -0.9517
    },
    {
      "sent": "(4) Includes as of April 25, 2022, one inactive smoking and health case alleging personal injury and purporting to be brought on behalf of a class of individual plaintiffs and two inactive class action lawsuits alleging that use of the terms \u201cLights\u201d and \u201cUltra Lights\u201d constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment, breach of warranty or violations of RICO.",
      "score": -0.9517
    },
    {
      "sent": "The terms of the court-approved settlement in that case allowed class members to file individual lawsuits seeking compensatory damages, but prohibited them from seeking punitive damages.",
      "score": -0.8898
    }
  ],
  "forward_snippets": [
    "This guidance simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity\u2019s own equity.",
    "For a description of issued accounting guidance applicable to, but not yet adopted by, us, see Note 11.",
    "New Accounting Guidance Not Yet Adopted .",
    "This guidance simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity\u2019s own equity.",
    "For a description of issued accounting guidance applicable to, but not yet adopted by, us, see Note 11."
  ],
  "curated_text": "Symbol: MO. Year: 2022. Period: Q3. ReportType: Q10. Section: Management Discussion and Analysis (MD&A). Key metrics include sentiment, forward outlook, and risk hedging.  Top positive sentences: 34 Table of Contents Consolidated Results of Operations for the Three Months Ended March 31, 2022 The changes in net earnings attributable to Altria and diluted earnings per share (\u201cEPS\u201d) attributable to Altria for the three months ended March 31, 2022, from the three months ended March 31, 2021, were due primarily to the following: (in millions, except per share data) Net Earnings Diluted EPS For the three months ended March 31, 2021 $ 1,424 $ 0.77 2021 NPM Adjustment Items (24) (0.01) 2021 Asset impairment, exit, implementation, acquisition and disposition-related costs 37 0.02 2021 Tobacco and health and certain other litigation items 26 0.01 2021 JUUL changes in fair value 200 0.10 2021 ABI-related special items (100) (0.05) 2021 Cronos-related special items (70) (0.04) 2021 Loss on early extinguishment of debt 496 0.27 2021 Income tax items (6) \u2014 Subtotal 2021 special items 559 0.30 2022 NPM Adjustment Items 45 0.02 2022 Asset impairment, exit, implementation, acquisition and disposition-related costs (5) \u2014 2022 Tobacco and health and certain other litigation items (9) \u2014 2022 JUUL changes in fair value (100) (0.05) 2022 ABI-related special items 47 0.02 2022 Cronos-related special items (61) (0.03) 2022 Income tax items (5) \u2014 Subtotal 2022 special items (88) (0.04) Fewer shares outstanding \u2014 0.02 Change in tax rate (4) \u2014 Operations 68 0.03 For the three months ended March 31, 2022 $ 1,959 $ 1.08 2022 Reported Net Earnings $ 1,959 $ 1.08 2021 Reported Net Earnings $ 1,424 $ 0.77 % Change 37.6 % 40.3 % 2022 Adjusted Net Earnings and Adjusted Diluted EPS $ 2,047 $ 1.12 2021 Adjusted Net Earnings and Adjusted Diluted EPS $ 1,983 $ 1.07 % Change 3.2 % 4.7 % For a discussion of special items and other business drivers affecting the comparability of statements of earnings amounts and reconciliations of adjusted earnings attributable to Altria and adjusted diluted EPS attributable to Altria, see the Consolidated Operating Results section below. 34 Table of Contents Consolidated Results of Operations for the Three Months Ended March 31, 2022 The changes in net earnings attributable to Altria and diluted earnings per share (\u201cEPS\u201d) attributable to Altria for the three months ended March 31, 2022, from the three months ended March 31, 2021, were due primarily to the following: (in millions, except per share data) Net Earnings Diluted EPS For the three months ended March 31, 2021 $ 1,424 $ 0.77 2021 NPM Adjustment Items (24) (0.01) 2021 Asset impairment, exit, implementation, acquisition and disposition-related costs 37 0.02 2021 Tobacco and health and certain other litigation items 26 0.01 2021 JUUL changes in fair value 200 0.10 2021 ABI-related special items (100) (0.05) 2021 Cronos-related special items (70) (0.04) 2021 Loss on early extinguishment of debt 496 0.27 2021 Income tax items (6) \u2014 Subtotal 2021 special items 559 0.30 2022 NPM Adjustment Items 45 0.02 2022 Asset impairment, exit, implementation, acquisition and disposition-related costs (5) \u2014 2022 Tobacco and health and certain other litigation items (9) \u2014 2022 JUUL changes in fair value (100) (0.05) 2022 ABI-related special items 47 0.02 2022 Cronos-related special items (61) (0.03) 2022 Income tax items (5) \u2014 Subtotal 2022 special items (88) (0.04) Fewer shares outstanding \u2014 0.02 Change in tax rate (4) \u2014 Operations 68 0.03 For the three months ended March 31, 2022 $ 1,959 $ 1.08 2022 Reported Net Earnings $ 1,959 $ 1.08 2021 Reported Net Earnings $ 1,424 $ 0.77 % Change 37.6 % 40.3 % 2022 Adjusted Net Earnings and Adjusted Diluted EPS $ 2,047 $ 1.12 2021 Adjusted Net Earnings and Adjusted Diluted EPS $ 1,983 $ 1.07 % Change 3.2 % 4.7 % For a discussion of special items and other business drivers affecting the comparability of statements of earnings amounts and reconciliations of adjusted earnings attributable to Altria and adjusted diluted EPS attributable to Altria, see the Consolidated Operating Results section below. 34 Table of Contents Consolidated Results of Operations for the Three Months Ended March 31, 2022 The changes in net earnings attributable to Altria and diluted earnings per share (\u201cEPS\u201d) attributable to Altria for the three months ended March 31, 2022, from the three months ended March 31, 2021, were due primarily to the following: (in millions, except per share data) Net Earnings Diluted EPS For the three months ended March 31, 2021 $ 1,424 $ 0.77 2021 NPM Adjustment Items (24) (0.01) 2021 Asset impairment, exit, implementation, acquisition and disposition-related costs 37 0.02 2021 Tobacco and health and certain other litigation items 26 0.01 2021 JUUL changes in fair value 200 0.10 2021 ABI-related special items (100) (0.05) 2021 Cronos-related special items (70) (0.04) 2021 Loss on early extinguishment of debt 496 0.27 2021 Income tax items (6) \u2014 Subtotal 2021 special items 559 0.30 2022 NPM Adjustment Items 45 0.02 2022 Asset impairment, exit, implementation, acquisition and disposition-related costs (5) \u2014 2022 Tobacco and health and certain other litigation items (9) \u2014 2022 JUUL changes in fair value (100) (0.05) 2022 ABI-related special items 47 0.02 2022 Cronos-related special items (61) (0.03) 2022 Income tax items (5) \u2014 Subtotal 2022 special items (88) (0.04) Fewer shares outstanding \u2014 0.02 Change in tax rate (4) \u2014 Operations 68 0.03 For the three months ended March 31, 2022 $ 1,959 $ 1.08 2022 Reported Net Earnings $ 1,959 $ 1.08 2021 Reported Net Earnings $ 1,424 $ 0.77 % Change 37.6 % 40.3 % 2022 Adjusted Net Earnings and Adjusted Diluted EPS $ 2,047 $ 1.12 2021 Adjusted Net Earnings and Adjusted Diluted EPS $ 1,983 $ 1.07 % Change 3.2 % 4.7 % For a discussion of special items and other business drivers affecting the comparability of statements of earnings amounts and reconciliations of adjusted earnings attributable to Altria and adjusted diluted EPS attributable to Altria, see the Consolidated Operating Results section below. Top negative sentences: (4) Includes as of April 25, 2022, one inactive smoking and health case alleging personal injury and purporting to be brought on behalf of a class of individual plaintiffs and two inactive class action lawsuits alleging that use of the terms \u201cLights\u201d and \u201cUltra Lights\u201d constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment, breach of warranty or violations of RICO. (4) Includes as of April 25, 2022, one inactive smoking and health case alleging personal injury and purporting to be brought on behalf of a class of individual plaintiffs and two inactive class action lawsuits alleging that use of the terms \u201cLights\u201d and \u201cUltra Lights\u201d constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment, breach of warranty or violations of RICO. The terms of the court-approved settlement in that case allowed class members to file individual lawsuits seeking compensatory damages, but prohibited them from seeking punitive damages. Forward-looking snippets: This guidance simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity\u2019s own equity. For a description of issued accounting guidance applicable to, but not yet adopted by, us, see Note 11. New Accounting Guidance Not Yet Adopted . This guidance simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity\u2019s own equity. For a description of issued accounting guidance applicable to, but not yet adopted by, us, see Note 11."
}